Munar Pharma

Munar Pharma EBITDA per Share

Delisted

The EBITDA per Share of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -0.02 PLN. In the previous year, EBITDA per Share was -0.01 PLN — a change of 153.17% (lower).

EBITDA per Share

-0.02PLN

YoY

153.17%

Last updated:

EBITDA per Share of Munar Pharma is 2024 -0.02 PLN. EBITDA per Share of Munar Pharma was 2023 -0.01 PLN. It decreases by 153.17% lower compared to the previous year.

The Munar Pharma EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2017
-0.01 PLN
Jan 1, 2018
-0.10 PLN
Jan 1, 2019
-0.00 PLN
Jan 1, 2020
-0.10 PLN
Jan 1, 2021
-0.07 PLN
Jan 1, 2022
0.01 PLN
Jan 1, 2023
-0.01 PLN
Jan 1, 2024
-0.02 PLN
The Munar Pharma EBITDA per Share history
YEAREBITDA per ShareYoY
-0.02PLN+153.17%
-0.01PLN-181.45%
0.01PLN-117.69%
-0.07PLN-32.58%
-0.10PLN+15,583.31%
-0.00PLN-99.40%
-0.10PLN+1,280.90%
-0.01PLN-960.18%
0.00PLN-51.81%
0.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

EBITDA per Share of Munar Pharma is -0.02 PLN in 2024.

EBITDA per Share of Munar Pharma changed from -0.01 PLN to -0.02 PLN, representing a 153.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Munar Pharma

All Key Metrics — Munar Pharma